Atlas Trials

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma

Clinical trial NCT00165633 · TERMINATED

Trial details

NCT number
NCT00165633
Sponsor
Eisai Limited
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2004-03-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.